LIGAND PHARMACEUTICALS INC (LGNDZ) Net income 2016–2025
LIGAND PHARMACEUTICALS INC (LGNDZ) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$124.5MFY2025 · since FY2016: -$1.6M → $124.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $124.5M | +3186.6% |
| FY2024 | -$4.0M | -107.7% |
| FY2023 | $52.2M | +256.3% |
| FY2022 | -$33.4M | -158.4% |
| FY2021 | $57.1M | +2014.2% |
| FY2020 | -$3.0M | -100.5% |
| FY2019 | $629.3M | +339.1% |
| FY2018 | $143.3M | +1041.5% |
| FY2017 | $12.6M | +867.5% |
| FY2016 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice